Overview of Dr. Doroshow
Dr. Deborah Doroshow is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, and Mount Sinai Beth Israel. She received her medical degree from Harvard Medical School and has been in practice 3 years. She is one of 188 doctors at The Mount Sinai Hospital and one of 73 doctors at Mount Sinai West who specialize in Oncology. She has more than 30 publications and over 500 citings.
Office
1 Gustave Levy Place
New York, NY 10029
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2020- Yale-New Haven Medical CenterResidency, Internal Medicine, 2013 - 2015
Harvard Medical SchoolClass of 2013
Yale UniversityPh.D., History of Medicine, 2007 - 2012
Certifications & Licensure
NJ State Medical License 2022 - 2025
NY State Medical License 2019 - 2025
CT State Medical License 2015 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2019 Jul 25
- Pembrolizumab for Advanced NSCLC and PS 2-3 Start of enrollment: 2023 May 26
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Financial Toxicity Among Patients With Advanced Solid Tumors Participating in Early-Phase Clinical Trials.Julia Blanter, Grace Van Hyfte, Maham Ahmad, Suzanne Xu, Olivia Hapanowicz
JCO Oncology Practice. 2024-12-11 - 1 citationsOptimizing care in early phase cancer trials: The role of palliative care.Fionnuala Crowley, Richard Sheppard, Stephanie Lehrman, Eve Easton, Thomas U Marron
Cancer Treatment Reviews. 2024-07-01 - C-reactive protein (CRP) as a prognostic biomarker in patients with urothelial carcinoma: A systematic review and meta-analysis.Yu Fujiwara, Alexander B Karol, Himanshu Joshi, Emma Reford, Sudeh Izadmehr
Critical Reviews in Oncology/hematology. 2024-05-01
Press Mentions
Dave Boule Confronted Polycythemia Vera with an Accountant’s ConsistencyJune 17th, 2022- Cancer Clinical Trials Bounce Back After Significant COVID-19 Disruption: Data from Two Large US Cancer CentersJune 15th, 2022
- Books That Mattered to Me This YearAugust 6th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
